STOCK TITAN

Intercept to Announce Fourth Quarter and Full Year 2021 Financial Results on March 2, 2022

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Intercept Pharmaceuticals (Nasdaq:ICPT) will report its Q4 and full year 2021 financial results before market opens on March 2, 2022. Following the announcement, an 8:30 a.m. ET conference call will be hosted by the management team to discuss the results. The call can be accessed on the investor page of their website or by calling a designated number. Intercept focuses on developing therapeutics for progressive liver diseases, including primary biliary cholangitis and nonalcoholic steatohepatitis.

Positive
  • None.
Negative
  • None.

NEW YORK, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its fourth quarter and full year 2021 financial results prior to market open on Wednesday, March 2, 2022. The announcement will be followed by a conference call and audio webcast hosted by Intercept management at 8:30 a.m. ET to discuss the results.

The conference call will be available on the investor page of our website at http://ir.interceptpharma.com or by calling (855) 232-3919 (toll-free) passcode 3258502. Archived webcasts will be available on Intercept’s website for approximately two weeks.

About Intercept
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn.

CONTACT

For more information about Intercept, please contact:

Investor inquiries:  investors@interceptpharma.com 

Media inquiries: media@interceptpharma.com


FAQ

When will Intercept Pharmaceuticals announce its Q4 2021 financial results?

Intercept Pharmaceuticals will announce its Q4 2021 financial results on March 2, 2022.

What time is the Intercept Pharmaceuticals conference call?

The conference call for Intercept Pharmaceuticals will be held at 8:30 a.m. ET on March 2, 2022.

How can I access the Intercept Pharmaceuticals conference call?

You can access the Intercept Pharmaceuticals conference call on their investor page or by calling (855) 232-3919.

What is the focus of Intercept Pharmaceuticals?

Intercept Pharmaceuticals focuses on developing therapeutics for progressive non-viral liver diseases.

Intercept Pharmaceuticals Inc

NASDAQ:ICPT

ICPT Rankings

ICPT Latest News

ICPT Stock Data

794.69M
40.45M
3.13%
81.3%
24.24%
Biotechnology
Healthcare
Link
United States
Morristown